Neuralert Monitor for Stroke Detection
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new device called the Neuralert Monitoring System to determine if it can detect strokes faster than current methods. Participants will wear the device on each arm for up to five days while researchers assess its compatibility with hospital systems and ease of use. The trial targets patients undergoing heart or blood vessel surgeries who are at high risk for stroke due to conditions like atrial fibrillation or a history of strokes. Individuals who have had heart surgery and are concerned about strokes may find this trial suitable. As a Phase 2 trial, the research focuses on evaluating the device's effectiveness in an initial, smaller group, providing an opportunity to contribute to advancements in stroke detection.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial team or your doctor.
What prior data suggests that the Neuralert Monitoring System is safe for stroke detection?
Research shows that the Neuralert Monitoring System is a non-invasive, lightweight wristband. It detects signs of a stroke by tracking arm movements and can alert hospital staff quickly, often faster than traditional methods.
Since this trial is in its early stages, data on the safety of the Neuralert device remains limited. However, because it doesn't enter the body, it is generally expected to be safe. Non-invasive devices usually pose fewer risks than treatments involving surgery or medication.
In this phase of the trial, researchers are primarily assessing how well the device functions in a hospital setting, including its connectivity and battery life. The focus is more on usability rather than safety concerns. If major safety issues existed, earlier studies likely would have identified them.12345Why are researchers excited about this trial?
The Neuralert Monitoring System is unique because it offers a real-time, continuous monitoring approach for stroke detection, which could be a game-changer for cardiac surgery patients. Unlike traditional methods that rely on periodic assessments or subjective symptom reporting, this system uses advanced sensors to detect early signs of a stroke as they happen. Researchers are excited because this could lead to quicker interventions and potentially better outcomes, reducing the risk of severe complications.
What evidence suggests that the Neuralert Monitoring System is effective for stroke detection?
Studies have shown that the Neuralert Monitoring System, used by participants in this trial, detects strokes about ten times faster than current hospital methods. Quick detection can save lives by identifying a stroke early, leading to better recovery and shorter hospital stays. The system uses wristbands with a smart program that quickly alerts medical staff to stroke symptoms. Research published by the American Heart Association supports the effectiveness of Neuralert's program in hospital patients. These findings suggest that Neuralert could be a powerful tool for detecting and treating strokes.12367
Are You a Good Fit for This Trial?
This trial is for individuals who are undergoing surgery and are at risk of stroke. Participants will be monitored using the Neuralert system to detect potential strokes early. The device will be worn on each arm for up to five days, or until battery life ends.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Monitoring
Participants are monitored using the Neuralert device to detect strokes and assess device connectivity, data transmission, and usability.
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Neuralert Monitoring System
Neuralert Monitoring System is already approved in United States for the following indications:
- Stroke detection in hospitalized patients
Find a Clinic Near You
Who Is Running the Clinical Trial?
Neuralert Technologies LLC
Lead Sponsor